John Aballi - Net Worth and Insider Trading

John Aballi Net Worth

The estimated net worth of John Aballi is at least $4 Million dollars as of 2025-04-26. John Aballi is the President and CEO of Exagen Inc and owns about 689,799 shares of Exagen Inc (XGN) stock worth over $4 Million. Details can be seen in John Aballi's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John Aballi has not made any transactions after 2024-11-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of John Aballi

To

John Aballi Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, John Aballi owns 1 companies in total, including Exagen Inc (XGN) .

Click here to see the complete history of John Aballi’s form 4 insider trades.

Insider Ownership Summary of John Aballi

Ticker Company Transaction Date Type of Owner
XGN Exagen Inc 2024-11-14 director & President and CEO

John Aballi Latest Holdings Summary

John Aballi currently owns a total of 1 stock. John Aballi owns 689,799 shares of Exagen Inc (XGN) as of November 14, 2024, with a value of $4 Million.

Latest Holdings of John Aballi

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
XGN Exagen Inc 2024-11-14 689,799 6.21 4,283,652

Holding Weightings of John Aballi


John Aballi Form 4 Trading Tracker

According to the SEC Form 4 filings, John Aballi has made a total of 4 transactions in Exagen Inc (XGN) over the past 5 years, including 3 buys and 1 sells. The most-recent trade in Exagen Inc is the acquisition of 24,305 shares on November 14, 2024, which cost John Aballi around $68,297.

Insider Trading History of John Aballi

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

John Aballi Trading Performance

GuruFocus tracks the stock performance after each of John Aballi's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John Aballi is 35.65%. GuruFocus also compares John Aballi's trading performance to market benchmark return within the same time period. The performance of stocks bought by John Aballi within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how John Aballi's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of John Aballi

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 33.11 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 32.27 LIMIT LIMIT LIMIT LIMIT LIMIT

John Aballi Ownership Network

Ownership Network List of John Aballi

No Data

Ownership Network Relation of John Aballi

Insider Network Chart

John Aballi Owned Company Details

What does Exagen Inc do?

Who are the key executives at Exagen Inc?

John Aballi is the director & President and CEO of Exagen Inc. Other key executives at Exagen Inc include 10 percent owner Nmsic Co-investment Fund, L.p. , Chief Financial Officer Kamal Adawi , and 10 percent owner Tullis Growth Fund Ii, L.p. .

Exagen Inc (XGN) Insider Trades Summary

Over the past 18 months, John Aballi made 2 insider transaction in Exagen Inc (XGN) with a net purchase of 64,706. Other recent insider transactions involving Exagen Inc (XGN) include a net sale of 550,000 shares made by Nmsic Co-investment Fund, L.p. , a net sale of 19,522 shares made by Kamal Adawi , and a net purchase of 22,298 shares made by Jeffrey G. Black .

In summary, during the past 3 months, insiders sold 350,000 shares of Exagen Inc (XGN) in total and bought 0 shares, with a net sale of 350,000 shares. During the past 18 months, 569,522 shares of Exagen Inc (XGN) were sold and 87,004 shares were bought by its insiders, resulting in a net sale of 482,518 shares.

Exagen Inc (XGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Exagen Inc Insider Transactions

No Available Data

John Aballi Mailing Address

Above is the net worth, insider trading, and ownership report for John Aballi. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, John Aballi's mailing address is: San Diego Ca 92121.